Patents
Patents for C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
11/2007
11/01/2007WO2005025490A3 Novel polyol macrolide antitumor-antibiotics from the novel marine actinomycete strain cnq140
10/2007
10/31/2007EP1848708A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007CN100344376C Recyclable chiral metathesis catalysts
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/17/2007EP1845099A1 Artemisine (qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/16/2007CA2205135C Novel 1,2-dioxetane compounds with haloalkoxy groups, methods of preparation and use
10/04/2007WO2007110415A2 Use of diacetyl trimers and cosmetic or therapeutic formulations containing these compounds
10/04/2007US20070229732 Chiral compounds
09/2007
09/27/2007US20070225498 Ultra-Sensitive Chemiluminescent Substrates for Enzymes and Their Conjugates
09/27/2007US20070225329 Aryl aniline beta2 adrenergic receptor agonists
09/27/2007US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/19/2007CN100338054C 手性化合物 Chiral compound
09/12/2007EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
09/12/2007EP1682528B1 BENZO [b][1,4] DIOXEPINE DERIVATIVES
09/11/2007US7268135 Biaryl sulfonamides and methods for using same
09/04/2007CA2242218C Process for preparing cyclobutane-1,2-dicarboxylic esters
08/2007
08/30/2007US20070203226 Calcium receptor antagonists; (R)-4-[(2-Indan-2-yl-1,1-dimethyl-ethylamino)-methyl]-6-oxo-2,5-dioxa-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene-14-carbonitrile; bone disorders; hypoparathyroidism, osteosarcoma, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral , osteoporosis
08/30/2007CA2643546A1 Anticancer agents
08/28/2007US7262236 Dibenzylidenesorbitol derivatives made by condensation, acetalization, and cyclization of benzaldehyde derivative and mono-, di-, or tri-acetal substituted alditol; nucleating, gelling, or clarifying agents; thickeners; plastic and/or polypropylene additive
08/22/2007CN1332957C Process for preparing ketal or acetal compounds with normal temperature ion liquid as catalyst
08/09/2007WO2007089310A1 Bipartite inhibitors of bacterial rna polymerase
08/08/2007EP1814537A2 Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
08/07/2007US7253185 Amino ceramide-like compounds and therapeutic methods of use
07/2007
07/31/2007US7250389 Cyclic diester substituted with an amine or amide group, a benzo group and a carbony or carboxyl group; high photostability, nontoxic to mammals and agricultural and garden plants
07/26/2007WO2007009201A3 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis
07/26/2007US20070173542 Peptide deformylase inhibitors
07/25/2007CN1328276C Method for preserving cyclic condensed formol
07/25/2007CN101006072A Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
07/24/2007US7247754 Method for the production of trimeric ketone peroxide solutions
07/18/2007CN101001849A Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
07/12/2007WO2007050380A3 Tyrosine kinase inhibitors
07/11/2007CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives
07/05/2007WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
07/04/2007EP1740653A4 Method of nucleating a polyolefin composition with acetal-based compounds
07/04/2007CN1993114A Diarylalkanes as potent inhibitors of binuclear enzymes
06/2007
06/27/2007CN1989100A Therapeutic compounds
06/26/2007US7235519 fragrance compositions for marine scented woman's fragrance
06/21/2007US20070142381 Calcium receptor modulating agents
06/20/2007CN1984949A Method of nucleating a polyolefin composition with acetal-based compounds
06/19/2007CA2154453C Fluorinated hydrocarbon compound, process for producing the same, and refrigerator oil and magnetic recording medium lubricant
06/12/2007US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties
06/12/2007CA2354023C Phenylglycine derivatives
06/07/2007WO2006074147A3 Nitrogen containing bicyclic compounds and therapeutical use thereof
06/06/2007CN1974550A Process for the preparation of compounds having a CF2O bridge
05/2007
05/29/2007US7223450 Chiral compounds
05/24/2007WO2007057658A1 Palladium catalysed heck arylation or vinylation of 1-substituted olefins
05/24/2007US20070117989 Methanesulfonic acid [7-(4-nitrophenyl)-(5H,9H)-6,8-dioxabenzocyclohepten-2-yl]methyl ester; chemical intermediates
05/23/2007EP1218368B1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS
05/03/2007CA2624676A1 Tyrosine kinase inhibitors
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
04/2007
04/26/2007WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
04/26/2007CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
04/25/2007CN1312157C Halogenated dihydroartemisine, preparation and use thereof
04/19/2007DE10290269B4 Verfahren zur Herstellung von zyklischem Formal A process for preparing cyclic formal
04/17/2007US7205401 Separation of such enantiomers with non-chromatographic resin bed separations of three separation stages or less; efficiency; chiral purity
04/12/2007WO2007039105A1 Chiral compounds
04/12/2007WO2007039104A1 Chiral compounds
04/11/2007CN1944423A Synthetic method for 2-methylene 1,3-cyclic heptane dioxide
04/04/2007EP1768970A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
03/2007
03/28/2007CN1307182C Preparation of bromo-dihydroartemisine
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/13/2007CA2286610C Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
03/07/2007CN1303076C Asymmetric benzaldehyde alditol derivatives, methods of making thereof, and compositions and articles containing same
02/2007
02/28/2007EP1756044A1 Therapeutic compounds
02/22/2007WO2005111134A3 Method of nucleating a polyolefin composition with acetal-based compounds
02/22/2007US20070043227 Process for producing alpha-methylstyrene
02/22/2007US20070042997 Medicament for treatment of dermal pigmentation
02/20/2007US7179927 Extraction method
02/14/2007CN1913880A Method for treating ADAMTS-5-associated disease
02/13/2007CA2531858C Nitrification inhibitors and the use of polyacids to treat mineral fertilizers containing a nitrification inhibitor
02/07/2007EP1748767A1 Diarylalkanes as potent inhibitors of binuclear enzymes
01/2007
01/31/2007EP1747213A1 Novel 7,7-disubstituted derivatives of (5h,9h)-6,8-dioxabenzocycloheptene, preparation method thereof and use of same in the synthesis of non-steroidal vitamin d analogues
01/25/2007WO2007009388A1 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof
01/25/2007WO2007009201A2 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis
01/24/2007CN1900081A Water soluble artemisine derivative and its preparing method, medicinal composition and use
01/17/2007EP1743899A1 Metal complexes for use in metathesis, atom transfer radical reactions, addition polymerisation and vinylation reactions, methods and intermediates for making them
01/17/2007CN1295231C Bromo-dihydroartemisine
01/10/2007EP1740653A2 Method of nucleating a polyolefin composition with acetal-based compounds
01/03/2007CN1889949A PDK-1/Akt signaling inhibitors
01/02/2007US7157510 Method of nucleating a polyolefin composition with acetal-based compounds
12/2006
12/20/2006EP1732908A1 Methods and intermediates for the synthesis of delta-9 tetrahydrocannabinol
12/20/2006EP1468004B1 Metal complexes for use in metathesis
12/14/2006WO2005108479A3 Acetal-based compositions
12/13/2006CN1289494C Esters compound of dibenzanthracene-1,3-dioxa-cyclooctane-2-amine carboxylic acid of possessing weeding activity
12/13/2006CN1289493C Compound of dibenzanthracene-1,3-dioxa-cyclooctane-2-amide class of possessing weeding activity
12/06/2006CN1875015A Benzo [b][1,4] dioxepine derivatives
11/2006
11/30/2006WO2006128126A1 Conversion of amorpha-4,11- diene to artemisinin and artemisinin precursors
11/30/2006US20060270738 Novel derivatives of 3,3-diphenylpropylamines
11/30/2006CA2609331A1 Conversion of amorpha-4,11- diene to artemisinin and artemisinin precursors
11/29/2006EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/23/2006WO2006123726A1 Pharmaceutical composition
11/23/2006WO2006061372A3 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
11/02/2006US20060247303 7H-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof
11/02/2006EP1301458A4 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
11/01/2006CN1856458A Process for producing a-methylstyrene
10/2006
10/26/2006WO2006036941A3 Specific kinase inhibitors
10/24/2006US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006CA2274183C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 21